BPC-157 Research Guide

What is BPC-157?

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide — a 15-amino-acid chain derived from a protein found in human gastric juice. Its sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) has been the subject of extensive preclinical research, primarily in animal models, since its discovery in the early 1990s.

The peptide has attracted significant research interest due to its observed effects across multiple tissue types and biological systems in laboratory studies. It is one of the most widely studied peptides in the tissue repair and regenerative medicine research space.

Mechanisms of Action

Published research suggests BPC-157 operates through several interconnected pathways:

Nitric Oxide System

Studies have demonstrated BPC-157's interaction with the nitric oxide (NO) system. Research by Seiwerth et al. (2014) showed that BPC-157 modulates NO synthesis, which plays a critical role in vascular function, inflammation regulation, and tissue healing processes. The peptide appears to both promote and counteract NO system effects depending on the physiological context.

Growth Factor Modulation

BPC-157 has been shown to upregulate growth factor expression in several tissue types. Studies indicate increased expression of VEGF (vascular endothelial growth factor), EGF (epidermal growth factor), and their respective receptors in treated tissue samples. This upregulation is associated with enhanced angiogenesis and tissue repair in preclinical models.

FAK-Paxillin Pathway

Research has identified BPC-157's influence on the focal adhesion kinase (FAK)-paxillin signalling pathway, which governs cell adhesion, migration, and proliferation. This pathway is fundamental to wound healing and tissue remodelling processes.

Key Research Areas

Gastrointestinal Studies

As a derivative of gastric juice protein, BPC-157 has been extensively studied in GI models. Research has documented protective effects against various gastric lesion models, including those induced by NSAIDs, alcohol, and stress. Studies by Sikiric et al. have demonstrated dose-dependent gastroprotective activity in rat models.

Musculoskeletal Research

Multiple studies have investigated BPC-157 in tendon, ligament, and muscle repair models. Research published in the Journal of Orthopaedic Research demonstrated accelerated healing of transected Achilles tendons in rat models, with improved biomechanical properties compared to controls.

Vascular Research

BPC-157 has shown significant effects in vascular studies, including promotion of angiogenesis in chick embryo models and rat wound models. Its interaction with the NO system suggests potential relevance to vascular biology research.

Handling and Storage

BPC-157 is typically supplied as a lyophilised (freeze-dried) white powder. For optimal stability:

• Long-term storage: -20°C in sealed vials, protected from light and moisture
• Short-term storage: 2-8°C (standard refrigerator)
• Reconstitution: Dissolve in bacteriostatic water or sterile water. Add solvent slowly along the vial wall and swirl gently — do not shake.
• Post-reconstitution: Store at 2-8°C and use within 14-21 days

For detailed reconstitution procedures, see our complete reconstitution guide.

Research Considerations

While BPC-157 research has produced promising preclinical results, researchers should note several important considerations:

• The majority of published research has been conducted in animal models (primarily rats)
• Human clinical trial data remains limited
• Dose-response relationships vary significantly across tissue types and experimental conditions
• Stability characteristics should be validated for each specific experimental protocol